Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Marrow cell genetic phenotype change induced by human lung cancer cells.
Del Tatto M, Ng T, Aliotta JM, Colvin GA, Dooner MS, Berz D, Dooner GJ, Papa EF, Hixson DC, Ramratnam B, Aswad BI, Sears EH, Reagan J, Quesenberry PJ. Del Tatto M, et al. Among authors: reagan j. Exp Hematol. 2011 Nov;39(11):1072-80. doi: 10.1016/j.exphem.2011.08.008. Epub 2011 Aug 22. Exp Hematol. 2011. PMID: 21864488 Free PMC article.
Cellular immunotherapy for refractory hematological malignancies.
Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, Butera JN, Quesenberry MI, Young CT, Quesenberry PJ. Reagan JL, et al. J Transl Med. 2013 Jun 19;11:150. doi: 10.1186/1479-5876-11-150. J Transl Med. 2013. PMID: 23782682 Free PMC article. Clinical Trial.
Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia.
Reagan JL, Fast LD, Nevola M, Mantripragada K, Mulder A, Claas FH, Rosati K, Schumacher A, Safran H, Young CT, Quesenberry MI, Winer ES, Butera JN, Quesenberry PJ. Reagan JL, et al. Blood Cancer J. 2015 Dec 4;5(12):e371. doi: 10.1038/bcj.2015.100. Blood Cancer J. 2015. PMID: 26636286 Free PMC article. Clinical Trial. No abstract available.
Extracellular vesicles in leukemia.
Pando A, Reagan JL, Quesenberry P, Fast LD. Pando A, et al. Leuk Res. 2018 Jan;64:52-60. doi: 10.1016/j.leukres.2017.11.011. Epub 2017 Nov 22. Leuk Res. 2018. PMID: 29190514 Review.
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease.
Ollila TA, Olszewski AJ, Butera JN, Quesenberry MI, Quesenberry PJ, Reagan JL. Ollila TA, et al. Among authors: reagan jl. Clin Lymphoma Myeloma Leuk. 2018 Mar;18(3):204-209. doi: 10.1016/j.clml.2018.01.007. Epub 2018 Jan 31. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29433979
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis.
Chorzalska A, Morgan J, Ahsan N, Treaba DO, Olszewski AJ, Petersen M, Kingston N, Cheng Y, Lombardo K, Schorl C, Yu X, Zini R, Pacilli A, Tepper A, Coburn J, Hryniewicz-Jankowska A, Zhao TC, Oancea E, Reagan JL, Liang O, Kotula L, Quesenberry PJ, Gruppuso PA, Manfredini R, Vannucchi AM, Dubielecka PM. Chorzalska A, et al. Among authors: reagan jl. Blood. 2018 Nov 8;132(19):2053-2066. doi: 10.1182/blood-2018-05-848408. Epub 2018 Sep 13. Blood. 2018. PMID: 30213875 Free PMC article.
392 results